The emergence of drug-resistant TB is a public health concern for several reasons. It is more difficult and costly to treat, requires longer treatment durations, and has lower treatment success rates compared to drug-susceptible TB. This increases the risk of transmission within communities, especially in settings with high TB burden and limited resources.
